Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 25 (TRIM25) is a cytoplasmic E3 ubiquitin ligase enzyme that belongs to the TRIM family, characterized by a RING domain, one or two B-box domains, a coiled-coil domain, and a C-terminal PRY/SPRY domain. It plays central roles in antiviral innate immunity primarily through ubiquitination of proteins such as RIG-I, a key sensor of viral RNA, leading to activation of the type I interferon pathway. TRIM25 also acts as an E3 ligase for ISG15, mediates ISGylation, and has RNA-binding activity important for its antiviral function. The protein is upregulated by estrogen and implicated in breast and ovarian cancers, as well as immune responses against viral infection, cancer progression, and inflammation. Viral proteins such as influenza NS1 interact with TRIM25 to evade host immune response by inhibiting RIG-I ubiquitination. TRIM25 is structurally complex: its RING domain enables E3 ligase activity, its CCD promotes dimerization, and the PRY/SPRY domain binds substrates such as RIG-I and MAVS. Its roles in ubiquitination, immune defense, and oncogenesis make it of therapeutic interest, though no approved drugs specifically target TRIM25 in the clinical setting.
Ubiquitination of target proteins (e.g., RIG-I) via Lys63- and Lys48-linked polyubiquitin chains; Conjugation of ISG15 (ISGylation) to target proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 25 (TRIM25).